Cargando…

Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited

Tailoring medical treatment to individual patients requires a strong foundation in research to provide the data necessary to understand the relationship between the disease, the patient, and the type of treatment advocated for. Non-therapeutic oncology clinical trials studying therapeutic resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Black, Lee, Batist, Gerald, Avard, Denise, Rousseau, Caroline, Diaz, Zuanel, Knoppers, Bartha Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593189/ https://www.ncbi.nlm.nih.gov/pubmed/23483771 http://dx.doi.org/10.3389/fphar.2013.00025

Ejemplares similares

Recruiting Terminally Ill Patients into Non-Therapeutic Oncology Studies: views of Health Professionals
por: Kleiderman, Erika, et al.
Publicado: (2012)

Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies
por: Batist, Gerald, et al.
Publicado: (2011)

Genomic medicine: considerations for health professionals and the public
por: Avard, Denise, et al.
Publicado: (2009)

Emerging issues in paediatric health research consent forms in Canada: working towards best practices
por: Dove, Edward S, et al.
Publicado: (2013)

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider
por: Black, Lee, et al.
Publicado: (2012)

Personalized medicine and access to health care: potential for inequitable access?
por: McClellan, Kelly A, et al.
Publicado: (2013)

To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015)

The ethics weathervane
por: Knoppers, Bartha Maria, et al.
Publicado: (2015)

International ethics harmonization and the global alliance for genomics and health
por: Knoppers, Bartha M
Publicado: (2014)

Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk
por: McClellan, Kelly A, et al.
Publicado: (2013)

Ethics approval in applications for open-access clinical trial data: An analysis of researcher statements to clinicalstudydatarequest.com
por: So, Derek, et al.
Publicado: (2017)

The Human Genome Organisation: towards next-generation ethics
por: Knoppers, Bartha Maria, et al.
Publicado: (2013)

An ethics safe harbor for international genomics research?
por: Dove, Edward S, et al.
Publicado: (2013)

The Adoption of Cloud Computing in the Field of Genomics Research: The Influence of Ethical and Legal Issues
por: Charlebois, Kathleen, et al.
Publicado: (2016)

Towards an ethics safe harbor for global biomedical research
por: Dove, Edward S., et al.
Publicado: (2014)

Genomic cloud computing: legal and ethical points to consider
por: Dove, Edward S, et al.
Publicado: (2015)

Preconception care and genetic risk: ethical issues
por: De Wert, Guido M. W. R., et al.
Publicado: (2011)

Geolocalisation of athletes for out-of-competition drug testing: ethical considerations. Position statement by the WADA Ethics Panel
por: Borry, Pascal, et al.
Publicado: (2018)

Ethics education for clinician–researchers in genetics: The combined approach
por: Zawati, Ma'n, et al.
Publicado: (2014)

Returning incidental findings from genetic research to children: views of parents of children affected by rare diseases
por: Kleiderman, Erika, et al.
Publicado: (2014)

Funding considerations for the disclosure of genetic incidental findings in biobank research
por: Black, L, et al.
Publicado: (2013)

Human gene editing: revisiting Canadian policy
por: Knoppers, Bartha Maria, et al.
Publicado: (2017)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
por: Geng, Meng, et al.
Publicado: (2020)

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
por: Agrawal, Samir, et al.
Publicado: (2019)

Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting
por: Fernandez, Conrad V., et al.
Publicado: (2013)

Ethical expertise revisited
por: Gordijn, Bert, et al.
Publicado: (2008)

Clinical ethics revisited
por: Singer, Peter A, et al.
Publicado: (2001)

Resveratrol: French Paradox Revisited
por: Catalgol, Betul, et al.
Publicado: (2012)

Apamin structure and pharmacology revisited
por: Kuzmenkov, Alexey I., et al.
Publicado: (2022)

Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
por: Lim, Sheng Zhang, et al.
Publicado: (2018)

Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
Publicado: (2023)

Genotype-driven recruitment: a strategy whose time has come?
por: Budin-Ljøsne, Isabelle, et al.
Publicado: (2013)

Discussing motherhood when the oncological prognosis is dire: ethical considerations for physicians
por: Linkeviciute, Alma, et al.
Publicado: (2020)

What is synergy? The Saariselkä agreement revisited
por: Tang, Jing, et al.
Publicado: (2015)

Are trial participants adequately safeguarded by the ethics committees—the Indian scenario?
por: Thakkar, Karan, et al.
Publicado: (2014)

Clinical ethics revisited: responses
por: Benatar, Solomon R, et al.
Publicado: (2001)

Desflurane - Revisited
por: Kapoor, Mukul Chandra, et al.
Publicado: (2012)

Iron deficiency in the elderly population, revisited in the hepcidin era
por: Busti, Fabiana, et al.
Publicado: (2014)

A Revisit to the Pretargeting Concept—A Target Conversion
por: Liu, Guozheng
Publicado: (2018)

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology
por: Lazar, Vladimir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eb0qudigdk7a55q5757e45p2vp